Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$2.05B |
| 3 |
Alibaba
BABA
|
+$905M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$371M |
| 5 |
Kroger
KR
|
+$307M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.33B |
| 3 |
Microsoft
MSFT
|
+$961M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$803M |
| 5 |
Amazon
AMZN
|
+$740M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.8% |
| 2 | Healthcare | 9.1% |
| 3 | Financials | 9.05% |
| 4 | Consumer Discretionary | 8.76% |
| 5 | Communication Services | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Rocket Pharmaceuticals
RCKT
$376M
| $13.9M | ﹤0.01% |
663,981
-112,536
| -14% | -$2.03M |
|
1977
CALL
FedEx
FDX
$74.1B
| $13.9M | ﹤0.01% |
99,100
+10,900
| +12% | +$1.37M |
|
1978
iShares Gold Trust
IAU
$63.3B
| $13.9M | ﹤0.01% |
408,643
-30,317
| -7% | -$993K |
|
1979
CALL
Gen Digital
GEN
$16.9B
| $13.9M | ﹤0.01% |
699,000
-34,100
| -5% | -$694K |
|
1980
Flex
FLEX
$46.8B
| $13.8M | ﹤0.01% |
1,792,878
-320,452
| -15% | -$2.31M |
|
|
GNMK
1981
DELISTED
GenMark Diagnostics, Inc
GNMK
| $13.8M | ﹤0.01% |
940,184
+462,380
| +97% | +$4.7M |
|
1982
Tapestry
TPR
$31.5B
| $13.8M | ﹤0.01% |
1,040,428
-25,632
| -2% | -$364K |
|
|
INN
1983
Summit Hotel Properties
INN
$747M
| $13.8M | ﹤0.01% |
2,327,456
-77,368
| -3% | -$436K |
|
1984
iShares California Muni Bond ETF
CMF
$4.6B
| $13.8M | ﹤0.01% |
221,603
+10,355
| +5% | +$635K |
|
|
MSGN
1985
DELISTED
MSG Networks Inc.
MSGN
| $13.8M | ﹤0.01% |
1,383,637
+909,750
| +192% | +$10.4M |
|
1986
CALL
Bristol-Myers Squibb
BMY
$135B
| $13.8M | ﹤0.01% |
233,900
+54,200
| +30% | +$3.24M |
|
1987
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.61B
| $13.8M | ﹤0.01% |
320,630
+308,677
| +2,582% | +$13M |
|
1988
Beyond Meat
BYND
$327M
| $13.7M | ﹤0.01% |
102,562
-99,605
| -49% | -$11.8M |
|
1989
BOK Financial
BOKF
$8.79B
| $13.7M | ﹤0.01% |
243,436
+1,486
| +0.6% | +$76.1K |
|
1990
PUT
Constellation Brands
STZ
$22.4B
| $13.7M | ﹤0.01% |
78,500
+28,100
| +56% | +$4.68M |
|
1991
PUT
iShares MSCI Japan ETF
EWJ
$22.4B
| $13.7M | ﹤0.01% |
250,000
-1,500,000
| -86% | -$79.6M |
|
|
NTUS
1992
DELISTED
Natus Medical Inc
NTUS
| $13.7M | ﹤0.01% |
628,737
-67,219
| -10% | -$1.54M |
|
|
FFWM
1993
DELISTED
First Foundation Inc
FFWM
| $13.7M | ﹤0.01% |
839,408
+63,475
| +8% | +$853K |
|
|
RVNC
1994
DELISTED
Revance Therapeutics, Inc.
RVNC
| $13.7M | ﹤0.01% |
560,875
-170,659
| -23% | -$3.37M |
|
1995
LGI Homes
LGIH
$1.43B
| $13.7M | ﹤0.01% |
155,576
+55,083
| +55% | +$3.86M |
|
1996
Cardlytics
CDLX
$23.3M
| $13.7M | ﹤0.01% |
19,558
+1,950
| +11% | +$1.13M |
|
1997
CALL
Target
TGT
$67.3B
| $13.7M | ﹤0.01% |
114,100
-76,000
| -40% | -$8.67M |
|
1998
Kirby Corp
KEX
$7.08B
| $13.7M | ﹤0.01% |
255,202
-345,855
| -58% | -$17.7M |
|
|
CNXM
1999
DELISTED
CNX Midstream Partners LP
CNXM
| $13.7M | ﹤0.01% |
+2,053,489
| New | +$16.6M |
|
2000
Arcus Biosciences
RCUS
$3.62B
| $13.6M | ﹤0.01% |
550,367
+467,011
| +560% | +$12.6M |
|
Similar funds
Goldman Sachs's Q2 2020 Portfolio in Review
As of Q2 2020, Goldman Sachs held 5,697 positions worth $329B, up 16% from $284B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs withdrew a net $19.5B in Q2 2020, closing 535 positions and reducing 2,401 holdings. Its most notable exit was Allergan plc, an estimated $1.33B position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Goldman Sachs MarketBeta US Equity ETF worth $209M.
- Goldman Sachs's largest Q2 2020 buy was Goldman Sachs MarketBeta US Equity ETF: 4,910,076 shares worth $209M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $2.58B increase.
- Goldman Sachs's biggest Q2 2020 reduction was Apple, cutting an estimated $1.38B.
- Goldman Sachs fully exited Allergan plc in Q2 2020, selling an estimated $1.33B.
- Goldman Sachs's ten largest holdings make up 19% of its $329B portfolio in Q2 2020.
- Goldman Sachs opened 507 new positions and closed 535 in Q2 2020.
- Goldman Sachs's portfolio value rose 16% quarter-over-quarter to $329B.
Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.